Long circulating liposomes : old drugs and new therapeutics / edited by Martin C. Woodle, Gerrit Storm

Includes Bibliographical references and index.

Content
1. Long Circulating Liposome Therapeutics: From Concept to Clinical Reality.
2. Oncologic Agents in Sterically Stabilized Liposomes: Basic Considerations.
3. Liposomal Vincristine: The Central Role of Drug Retention in Defining Therapeutically Optimized Anticancer Formulations.
4. Long Circulating Liposome-Encapsulated Tumor Necrosis Factor in the Treatment of Solid Tumors
5. Therapy of Human Carcinoma Xenografts with Doxorubicin Encapsulated in Sterically Stabilized Liposomes (DOXIL (R)): Efficacy and Safety Studies
6. Design and Development of Long Circulating Liposomal Daunorubicin for In Vivo Targeting of Solid Tumors: DaunoXome (R).
7. Enhancement of Doxorubicin by Encapsulation in Long circulating Thermosensitive Liposomes Combined with Local Hyperthermia.
8. Liposomal Localization and Chemotherapy for AIDS-Related Kaposi's Sarcoma.
9. Pegylated-Liposomal Doxorubicin (Doxil (R)) in the Treatment of AIDS-Related Kaposi's Sarcoma.
10. DaunoXome (R) (Liposomal Daunorubicin) for First-Line Treatment of Advanced, HIV-Related Kaposi's Sarcoma.
11. Initial Clinical Evaluation of Pegylated-Liposomal Doxorubicin in Solid Tumors.
12. Antibacterial Therapy with Sterically Stabilized Liposome Formulations.
13. AmBisome (R): Long Circulating Liposomal Formulation of Amphotericin B.
14. Steric Stabilization of Liposomes Containing Amphotericin B: A Future Direction in Antifungal Therapy?.
15. Clinical and Preclinical Studies with Low-Clearance Liposomal Amikacin (MiKasome (R)).
16. Sterically Stabilized Liposomes to Image Infection and Inflammation.
17. Long Circulating Liposomes for Diagnostic Imaging.
18. Tumor Imaging with Long Circulating Liposomes.
19. Antibody-Mediated Targeting of PEG-Coated Liposomes.
20. Small Molecule Ligands for Targeting Long Circulating Liposomes.